SEC Form D · Amendment · filed November 2, 2017
Aura Biosciences, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Jose' E. Baselga, Ph.D · Cambridge, MADirectorElisabet De Los Pinos, Ph.D · Cambridge, MAExec · DirectorAlan E. Walts, Ph.D · Cambridge, MADirectorRaj E. Parekh, Ph.D · Cambridge, MADirectorJoel E. Jean-Mairet, Ph.D · Cambridge, MADirectorMichael E. Wyzga · Cambridge, MAExecArt E. Pappas · Cambridge, MADirectorDale E. Pfost, Ph.D · Cambridge, MADirectorLewis E. Geffen · Cambridge, MAExecPeter E. Wirth · Cambridge, MADirectorDeepak Sindwani · Boston, MAExecPhillip Chapple · Hamilton, BermudaExecDaniel M. Rosenbloom · CHICAGO, ILDirectorHarold D. Keller · Columbus, OHDirectorMatt Harris · CHARLOTTE, NCDirectorNigel Morris · CHARLOTTE, NCDirectorDenise A. Olsen · CHICAGO, ILExec · DirectorRichard L. Mcquady · Columbus, OHDirectorJohn P. Lee · Columbus, OHDirectorEric M. Siegal · CHICAGO, ILExec · DirectorRD Legal Capital, LLC · Cresskill, NJDirectorDennis S. Guest · Columbus, OHDirectorThomas T. Loos · Columbus, OHDirectorDaniel M. Slane · COLUMBUS, OHDirectorSusan E. Weaver · Columbus, OHDirectorMario M. Gutierrez · Seattle, WADirectorGrant G. Farwell · Seattle, WADirectorAnthony M. Farwell · Seattle, WAExecMichael A. Bruun · NEW YORK, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗